Assembly Biosciences Inc (ASMB)
16.14
-0.91
(-5.34%)
USD |
NASDAQ |
Nov 15, 16:00
16.14
0.00 (0.00%)
After-Hours: 20:00
Assembly Biosciences Research and Development Expense (TTM): 49.97M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 49.97M |
| March 31, 2024 | 46.23M |
| December 31, 2023 | 48.90M |
| September 30, 2023 | 54.75M |
| June 30, 2023 | 62.05M |
| March 31, 2023 | 67.32M |
| December 31, 2022 | 69.98M |
| September 30, 2022 | 67.87M |
| June 30, 2022 | 68.22M |
| March 31, 2022 | 67.18M |
| December 31, 2021 | 68.52M |
| September 30, 2021 | 87.29M |
| June 30, 2021 | 95.75M |
| March 31, 2021 | 102.33M |
| December 31, 2020 | 106.82M |
| September 30, 2020 | 95.93M |
| June 30, 2020 | 90.72M |
| March 31, 2020 | 86.10M |
| December 31, 2019 | 85.76M |
| September 30, 2019 | 84.39M |
| June 30, 2019 | 81.76M |
| March 31, 2019 | 80.90M |
| December 31, 2018 | 72.74M |
| September 30, 2018 | 62.09M |
| June 30, 2018 | 53.91M |
| Date | Value |
|---|---|
| March 31, 2018 | 48.19M |
| December 31, 2017 | 44.22M |
| September 30, 2017 | 42.25M |
| June 30, 2017 | 40.15M |
| March 31, 2017 | 35.55M |
| December 31, 2016 | 33.09M |
| September 30, 2016 | 29.70M |
| June 30, 2016 | 25.49M |
| March 31, 2016 | 22.64M |
| December 31, 2015 | 18.36M |
| September 30, 2015 | 16.11M |
| June 30, 2015 | 15.15M |
| March 31, 2015 | 11.58M |
| December 31, 2014 | 10.72M |
| September 30, 2014 | 12.90M |
| June 30, 2014 | 12.98M |
| March 31, 2014 | 15.39M |
| December 31, 2013 | 15.03M |
| September 30, 2013 | 12.61M |
| June 30, 2013 | 13.05M |
| March 31, 2013 | 15.70M |
| December 31, 2012 | 19.51M |
| September 30, 2012 | 34.31M |
| June 30, 2012 | 33.79M |
| March 31, 2012 | 30.73M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
46.23M
Minimum
Mar 2024
106.82M
Maximum
Dec 2020
74.83M
Average
68.52M
Median
Dec 2021
Research and Development Expense (TTM) Benchmarks
| ADMA Biologics Inc | 1.868M |
| Sensus Healthcare Inc | 3.552M |
| Protagonist Therapeutics Inc | 132.12M |
| Precision BioSciences Inc | 57.04M |
| Entrada Therapeutics Inc | 120.19M |